Trial Profile
Phase I Study of Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Dec 2022
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Adverse reactions
- 13 Dec 2022 Results published in the BMC Cancer
- 28 Jul 2022 Status changed from active, no longer recruiting to completed.
- 16 Feb 2021 Planned End Date changed from 31 Aug 2024 to 28 Feb 2025.